|S Andrikopoulos (Outgoing)
University of Melbourne, Australia
National Health and Medical Research Council of Australia (NH&MRC) Senior Research Fellow and head of the Islet Biology Research Group at the University of Melbourne Department of Medicine (Austin Health), which investigates the genetic susceptibility of islet dysfunction using animal models of diabetes.
University of Edinburgh-Roslin Institute, UK
Professor of Skeletal Biology within the Royal (Dick) School of Veterinary Studies. His research is focused on the fundamental cellular mechanisms underpinning bone and cartilage growth, development and function. Of particular interest is the GH-IGF-1 axis and its effects on bone formation and endochondral growth and how disease states e.g. chronic kidney disease, muscular dystrophy and inflammatory bowel disease impact on bone development and turnover. The mechanisms of skeletal mineralisation and in particular the role of phosphatases are also an ongoing research interest.
|M Haluzík (Elect)
Charles University, Czech Republic
Professor of Internal Medicine in the Charles University in Prague, Deputy Head of Centre for Experimental Medicine and Head of the Department of Experimental Diabetology in the Institute for Clinical and Experimental Medicine in Prague, Czech Republic. His major research focus is on the etiopathogenesis of obesity, insulin resistance and type 2 diabetes mellitus with special interest in endocrine function of adipose tissue, incretin system and novel hormonal factors involved in the regulation of energy homeostasis and glucose metabolism.
|B J Clark
University of Louisville School of Medicine, USA
Associate Professor of Biochemistry and Molecular Genetics at the University of Louisville, Louisville, Kentucky. Her research interests focus on defining the functions of the lipid transporters STARD1 in steroidogenesis, and STARD4 and STARD5 in cholesterol and bile acid homeostasis in normal and disease states; eg diabetic nephropathy, NAFLD and cholestasis.
The First Affiliated Hospital of Sun Yat-sen University, China
Professor Xiao is current President of the First Affiliated Hospital of Sun Yat-sen University, and holds numerous society positions including Presidency of Guangdong Endocrine and Metabolism Association in the Chinese Medical Doctor Association. Professor Xiao takes the lead in treating Graves’ diseases by introducing thyroid arterial embolization, and reported relevant findings of using innovative methods to treat Graves’ diseases. His research interests have focused mainly on thyroid disease and β-cell function of diabetes.
|Australasia/Endocrine Society of Australia|
|T J Cole
Monash University, Australia
Dr Cole is Deputy Head and an Associate Professor in the Department of Biochemistry and Molecular Biology at Monash University in Melbourne, and is an Honorary Research Associate of the Hudson Institute (Melbourne). He has been an elected member of the Executive Council of the Endocrine Society of Australia for the past ten years and is currently the President-Elect of the Society. His endocrine research program focusses on the cellular and physiological actions of adrenal steroid hormones during development and in the adult. Dr Cole also studies the role of short-chain alcohol dehydrogenase-reductase enzymes for pre-receptor regulation of nuclear receptor signalling.
|Europe/European Society of Endocrinology|
University of Turin, Italy
Associate Professor of Endocrinology, Department of Medical Sciences, University of Turin, Italy. She is currently member of the Executive Committee of the European Society of Endocrinology and of the Italian Society of Endocrinology. Her research interests include the peripheral effects of neurohormones, such as the ghrelin gene-derived peptides in pancreatic beta-cell function and survival and in glucose metabolism, the role of growth hormone-releasing hormone (GHRH) in the cardiovascular system and the antitumor effects of GHRH antagonists, along with the underlying mechanisms.
University of Buenos Aires, Argentina
Currently Head of the Department of Biochemistry, School of Medicine University of Buenos Aires and Director of the Biomedical Research Institute belongs to the Argentinean National Research Council. His research interests have centred on the role of intramitochondrial arachidonic acid and its metabolites in physiology (regulation of steroidogenesis) and pathology (breast cancer).
|Society for Endocrinology|
University of Glasgow, UK
Professor of Molecular Endocrinology at the University of Glasgow. Prof Davis leads a research group investigating the role of the mineralocorticoid aldosterone in cardiovascular disease. Her translational research focuses on the genetic and epigenetic regulation of aldosterone production by the adrenal gland and its action via the mineralocorticoid receptor and integrates basic molecular biology, cell biology and human population studies.
Augusta University, USA
Professor of Physiology and the Director of the Office of Postdoctoral Affairs at the Medical College of Georgia (MCG) at Augusta University. After earning her PhD in Cellular and Molecular Physiology at Yale University and performing an industrial postdoctoral fellowship at Hoffman-La Roche. Dr Bollag embarked on an academic career at MCG, where she rose through the ranks. Dr Bollag’s research interests relate to signal transduction and she has applied her expertise in cell signaling to a variety of systems, including the regulation of aldosterone production, of bone formation and of skin function.
University of Edinburgh, UK
Professor of Molecular Endocrinology in the Centre for Cardiovascular Science at the University of Edinburgh and an Adjunct Professor at the University of Western Australia. Professor Chapman’s research focuses on the actions of glucocorticoids, in immunity and inflammation and in fetal maturation. Her current research is focused on the role of glucocorticoids in maturation of the fetal and neonatal cardiovascular system and the consequences for the adult cardiovascular system. Professor Chapman is a long-standing member of the Society for Endocrinology and previously served as the General Secretary of the Society. She is a keen advocate of mentoring, postgraduate education and equality, diversity and inclusion.
|D W Ray
University of Manchester, UK
Currently Professor of Medicine and Endocrinology at the University of Manchester. He runs the clinical endocrinology service for the Manchester Royal Infirmary. His interests lie in the control of glucocorticoid production, and action, and the roles of nuclear receptors and the cellular clock in inflammation and energy metabolism.
Royal Veterinary Collage, UK
A Professor of Skeletal Biology at the Royal Veterinary College in London. Dr Chenu’s research interests are centred around the regulatory and repair mechanisms of bone as well as the interactions between osteoporosis and diabetes.
Hudson Institute of Medical Research, Australia
Head of Cardiovascular Endocrinology Laboratory at Hudson Institute of Medical Research. She joined Hudson in 2002 after completing a CJ Martin Postdoctoral Fellowship in the laboratory of the late Dr Keith Parker at University of Texas Southwestern Medical Centre, Dallas, Texas (USA) and at the Baker Institute of Medical Research (Melbourne, Australia). Her research focus addresses the cell-specific role of mineralocorticoid hormones and their receptors (the MR) in the cardiovascular system and to understand the mechanisms that translate MR signalling into cardiac tissue fibrosis and inflammation, and hypertension. A second major research interest is of cortisol regulation of the mineralocorticoid receptor in biology and disease.
Singapore Bioimaging Consortium, A*STAR Research Enterprises
Professor Weiping Han obtained his PhD in Physiology from Cornell University and did his postdoctoral work at the University of Pittsburgh and HHMI/UT Southwestern Medical Center. He was a Research Assistant Professor in the Center for Basic Neuroscience at UT Southwestern before moving to Singapore to establish a research program at Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR). Currently he is Deputy Director of SBIC with concurrent appointment as Head of Laboratory of Metabolic Medicine. He is also Research Director at Institute of Molecular and Cell Biology, A*STAR; Professor of Biochemistry at National University of Singapore and Duke-NUS Medical School.
University of Washington and VA Puget Sound Health Care System, USA
Research Associate Professor at the University of Washington and VA Puget Sound Health Care System in Seattle. Her long-standing research interest is in understanding the mechanisms underlying decreased islet failure in type 2 diabetes. Her current research focus is on the islet endothelial cell and its role in modulating β-cell function and survival under conditions of health and disease. She is also Director of the Cellular and Molecular Imaging Core within the University of Washington’s Diabetes Research Center.
University of Dundee, UK
Dr Cantley’s research is focused on the mechanisms that control insulin and glucagon secretion from the pancreas to maintain glucose homeostasis. Of particular interest are how these mechanisms coordinate the pancreatic endocrine response with whole body metabolic status, how they adapt during obesity, and how they fail during diabetes. Dr Cantley is a Senior Lecturer and PI at the University of Dundee, and was previously a group leader and Diabetes UK RD Lawrence Fellow at the University of Oxford.
McMaster University, Canada
Dr Steinberg received his PhD in 2002 and is a professor of medicine at McMaster University where he holds a Canada Research Chair and a J Bruce Duncan Endowed Chair in Metabolic Diseases. His research studies cellular energy sensing mechanisms and how endocrine factors, lipid metabolism and insulin sensitivity are linked and contribute to the development of obesity, type 2 diabetes and cardiovascular disease. His scientific contributions have been recognized by the Endocrine Society, the American Diabetes Association, Diabetes Canada and the Canadian Institutes of Health Research who have each presented him with outstanding scientific achievement awards.
Second Military Medical University, China
Currently Chairman of the Department of Pathophysiology, Second Military Medical University, China. He is also Head of the Center for Obesity & Diabetes Research and Innovation at the University. His research interests mainly focus on diabetes, insulin secretion, and hepatic lipid metabolism.
Imperial College London, UK
Professor of molecular endocrine oncology at Imperial College London. He leads a research group investigating the mechanisms of gene regulation by nuclear receptor transcription factors, with particular focus on estrogen and androgen receptor action in breast and prostate cancer, respectively, and treatment failure. His interests include genomic profiling, new target identification and development of drugs targeting transcriptional processes in cancer.
|R M Luque
University of Córdoba, Spain
Professor of Cell Biology at the Department of Cell Biology, Physiology and Immunology of the University of Córdoba, and head the Hormones and Cancer Research Group, Maimonides Institute for Biomedical Research of Córdoba, Spain. His research focuses on the regulation of pituitary cells by neuropeptides (e.g. somatostatin, GHRH, ghrelin), and on the molecular biology and functional relevance of these and other neuropeptides and their receptors on pituitary adenomas and hormone-related cancers.
University of Coimbra, Portugal
Dr Carvalho is Principle Investigator at the Centre for Neuroscience and Cell Biology (CNC) at the University of Coimbra, and leads the group that studies obesity, diabetes and complications. She is currently investigating insulin action and metabolic dysfunction in adipocytes in response to in vivo treatments with immunosuppressive and antipsychotic drugs. Dr Carvalho is interested in investigating systemic and local factors that are altered in obesity and diabetes and identify dysfunctional pathways, including insulin signalling, mitochondrial function, oxidative stress and inflammation in cells and tissues, including epicardial fat in subjects with heart failure with diabetes.
|C García Cáceres
Helmholtz Zentrum Munchen, Germany
Lead of the the Astrocyte-Neuron Network Division, and Deputy Director at the Institute for Diabetes and Obesity (HMGU, Munich, Germany). Her research interests lie in the identification of key astrocytic signaling and molecular pathways implicated in the progression of obesity, thus inspiring and redefining therapeutic strategies to fight diabetes and obesity.
AgResearch Limited, New Zealand
Principal Scientist with the Animal Reproduction team at AgResearch Limited, a Crown Research Institute in New Zealand. Her current work primarily focuses on the elucidation of the mechanisms involved in the development, growth, maturation and health of the ovarian follicle and the oocyte to identify pathways that regulate reproductive efficiency.
University of Arizona, USA
Professor of Endocrinology in the School of Animal and Comparative Biomedical Sciences at the University of Arizona, Tucson, Arizona, USA. His research interests are centered on fetal endocrinology and metabolism in normal pregnancy and pregnancies compromised by pathology, such as intrauterine growth restriction and diabetes.
|Steroid and Steroidogenesis|
|A J Conley
University of California, USA
Professor of Population Health & Reproduction and Director of the Clinical Endocrinology Laboratory in the School of Veterinary Medicine, UC Davis. He is a comparative reproductive biologist and molecular endocrinologist with interests in steroidogenesis of the gonads, placenta and developing adrenal cortex as it relates to mammalian pregnancy and parturition as well as in endocrine diseases of the gonads and adrenals of domestic animals.
University of Arkansas for Medical Sciences, USA
Full Professor, Department of Physiology & Biophysics and the Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, USA. Her research centres on women's reproductive health, obesity and chronic diseases, steroid hormone signalling, and metabolic networks and programming of breast and uterine cancers and stem cells.
University of Amsterdam, the Netherlands
A senior researcher in the Laboratory of Endocrinology at the Academic Medical Center of the University of Amsterdam. She is also in charge of the regional Dutch Neonatal Screening program at the Laboratory of Endocrinology in the same institution. Her research primarily focuses on the pathogenesis of altered thyroid hormone metabolism during illness (NTIS) and the role of altered thyroid hormone metabolism in T3-target tissues and cells.
Centre National de la Recherche Scientifique (CNRS), Paris, France
Head of the joint research unit Molecular Physiology and Adaption, affiliated to the Centre National de la Recherche Scientifique (CNRS) and the National Museum of Natural History of Paris. Dr Sachs’s research interests focus on the functions and mechanisms of action of thyroid hormones to understand physiological regulations that control development, tissue homeostasis, regeneration and aging in normal and altered conditions. Recently, his work has focused on the evolution of the hormonal control of life cycle transition with a special emphasis on amphibian metamorphosis and the crosstalk between thyroid hormone and glucocorticoid signalling.
|A Orozco Rivas
National University of Mexico, Mexico
Aurea Orozco is currently a researcher at the Neurobiology Institute, National University of Mexico. Her research interests are centred in the comparative thyroid function field, studying thyroid hormone metabolism and action mechanisms in non-mammalian vertebrates.
Open University, UK
Emeritus Professor of Applied Statistics at the Open University in the UK. His research interests are in Bayesian methods and in applications of statistics in the life sciences (particularly ecology, evolution and clinical medicine). He studied at Cambridge, UCL and the Open University, is a trustee of the UK’s Science Media Centre and has been a Vice-President of the Royal Statistical Society.
|EARLY CAREER EDITORS|
University of Birmingham, UK
Dr Caroline Gorvin is a senior research fellow within the Institute of Metabolism and Systems Research and the Centre of Membrane Proteins and Receptors at the University of Birmingham. Dr Gorvin’s research investigates how impairments in the trafficking and signalling of membrane proteins contribute to endocrine disorders. This previously focussed on how genetic alterations in the calcium-sensing receptor cause disorders of calcium homeostasis, reviews of which she has recently published in Journal of Molecular Endocrinology. She is currently establishing her research group investigating how metabolic G protein-coupled receptors integrate hormonal signals to regulate appetite.
University of Birmingham, UK
Dr Zoi Michailidou is currently a principal investigator, University of Edinburgh. Shecompleted her PhD in Molecular Endocrinology at the University of Edinburgh, then moved to Oxford with a Henry Wellcome Postdoctoral Fellowship (Wellcome Trust) to study the oxygen sensing pathway in fat cell function, under the mentorship of Sir Peter Ratcliffe. Following a BHF transition fellowship and Edinburgh scientific tenure track fellowship, her research interests are centred around oxygen sensing signalling in fat cells and its role in diabetes, fatty liver and obesity-related cancer. Zoi is one of the recipients of the innovative Leadership Award Scheme (Society for Endocrinology).
|D Bechtold||UK||M Huising||USA||B Soria||Spain|
|F Beier||Canada||S Jonker||USA||K Staines||UK|
|M Björnholm||Sweden||R O Karlstrom||USA||S Tsai||Taiwan|
|M Caprio||Italy||S Mader||Canada||C Too||Canada|
|J Carroll||UK||L Maletinska||Czech Republic||W E Visser||Netherlands|
|H Choi||Republic of Korea||G Mabilleau||France||A Warner||UK|
|A Erson-Bensan||Turkey||J Mueller||UK||L Weinstein||USA|
|B Fam||Australia||O Nilsson||Sweden||Q Winger||USA|
|M Fex||Sweden||L Orbán||Singapore||J Wolfe-Muller||UK|
|D Heery||USA||P Rozance||USA||Q Zhai||China|
Editors' declarations are listed in the journal's Disclosure Policy